Abstract-Focal recruitment of monocytes and lymphocytes is one of the earliest detectable cellular responses in the formation of lesions of atherosclerosis. This localized accumulation of leukocytes is a multistep process in which the endothelium remains intact and may regulate leukocyte recruitment by expressing specific adhesion molecules. To examine the relationship of adhesion molecule expression to initiation factors and the sites of lesion formation, we analyzed the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and platelet-endothelial cell adhesion molecule-1 (PECAM-1) en face on the aortic endothelium of control mice and homozygous apolipoprotein E-deficient (ApoE Ϫ/Ϫ) mice that develop complex lesions of atherosclerosis similar to those in humans. In control mice, VCAM-1 staining was weak and limited to sites of altered blood flow. In contrast, in the ApoE Ϫ/Ϫ mice, VCAM-1 appeared to be localized over the surface of groups of endothelial cells in lesion-prone sites. Expression of VCAM-1 preceded lesion formation, and increased expression above control levels appeared to be correlated with the extent of exposure to plasma cholesterol. Although ICAM-1 was the most prominent adhesion molecule in lesion-prone sites, its expression appeared to be independent of plasma cholesterol levels and was upregulated in both ApoE Ϫ/Ϫ and control mice. At lesion-prone sites associated with altered blood flow, ICAM-1 was located over the surface of each endothelial cell and on microvilli, whereas VCAM-1 was confined to the cell periphery in non-lesion-prone sites. PECAM-1 was localized at the cell periphery throughout the aorta, and its expression did not appear to be regulated. Thus, the levels, localization, and characteristics of expression of VCAM-1, ICAM-1, and PECAM-1 appear to be differentially regulated. Upregulation of VCAM-1 and ICAM-1 is associated with sites of lesion formation. (Arterioscler Thromb Vasc Biol. 1998;18:842-851.)
O ne of the earliest detectable cellular responses in the formation of lesions of atherosclerosis is leukocyte adherence to the endothelium at particular anatomic sites in the artery wall. [1] [2] [3] As in other inflammatory responses, the leukocytes migrate across the EC barrier and accumulate in the subendothelial space, where some of the monocytes ingest lipid and become foam cells. However, atherosclerosis appears to be a specialized inflammatory response in which leukocyte recruitment occurs in lesion-prone areas of the arterial tree and results in subendothelial accumulation of monocytes and lymphocytes without granulocytes. This recruitment of specialized leukocytes persists so long as the condition of hypercholesterolemia continues in the subject. During that time, the vascular endothelium remains intact and participates in recruitment of leukocytes by expression of specific leukocyte adhesion molecules.
Distinct adhesion molecules appear to regulate different stages of leukocyte immigration at inflammatory sites in a multistep process. 4 The current model, based primarily on studies of neutrophils, suggests that emigration is regulated by at least three discrete molecular signals, which appear to act together or in sequence. The first step includes a primary and transient adhesion event, which allows "sampling" of the endothelial surface. In this step, endothelial P-and E-selectins, which bind carbohydrate ligands on leukocytes, 4 and the leukocyte integrin very late-acting antigen-4 interact with endothelially expressed VCAM-1. [5] [6] [7] [8] The first step, which allows flowing cells to tether and subsequently roll along the vessel wall, is followed by the second step, a rapid, activating event that increases adhesion and arrests the cell. Chemoattractants released from the tissue or localized on the surface of the endothelium transduce signals that activate integrin adhesiveness. Members of the immunoglobulin superfamily of endothelial adhesion molecules, including ICAM-1 and VCAM-1, mediate firm adhesion. In the final step, chemotaxis and transmigration take place across the endothelial lining into the tissue. Another member of the immunoglobulin superfamily, PECAM-1/CD31, is required for leukocyte transendothelial migration in vitro 9 and in vivo. 10 In this study, the thin and transparent aorta of the mouse made it possible to qualitatively evaluate the adhesion molecules expressed on the surface of the endothelium of the entire aorta by the use of whole-tissue mounts and in situ immunocytochemistry. Different time points were evaluated in ApoE Ϫ/Ϫ mice, in which a dramatic increase in plasma cholesterol levels is associated with spontaneous development of atherosclerosis, including fibroproliferative lesion formation. [11] [12] [13] [14] We compared specific anatomic sites of lesion development with the location of adhesion molecule expression. Adhesion molecules involved in all three steps of leukocyte recruitment have been evaluated: VCAM-1, which together with P-and E-selectin, is involved in the first step of tethering and rolling of monocytes and lymphocytes and in second-stage arrest and firm adhesion; ICAM-1, which helps mediate arrest and firm adhesion of lymphocytes, monocytes, and neutrophils; and PECAM-1, which appears to be involved in transendothelial cell migration. Our studies demonstrate that blood flow and plasma cholesterol levels appear to differentially regulate these three adhesion molecules and particularly support a role for VCAM-1, when it localizes at lesion-prone sites that manifest increased ICAM-1, in focal recruitment of monocytes and lymphocytes in developing lesions of atherosclerosis.
Methods

Reagents
The sources and working dilutions of both primary antibodies and irrelevant control immunoglobulins are listed in the Table. Using a cell-surface ELISA, Hahne et 15 al showed that antibodies to VCAM-1 and ICAM-1 react with antigens expressed on the surface of a mouse endothelioma cell line. Biotinylated rabbit anti-rat IgG (heavy and light chain) was obtained from Vector Laboratories, Inc. The 10-nm gold-labeled goat anti-rat IgG (HϩL), 10-nm goldlabeled streptavidin, and IntenSETM M silver enhancement kit were obtained from Amersham Corp. Normal mouse serum was obtained from Zymed Laboratories, Inc.
ApoE ؊/؊ and Control Mice
Homozygous ApoE Ϫ/Ϫ male mice, second-or third-generation hybrid 129olaϫC57BL/6, were derived from brother-sister matings. We used only ApoE Ϫ/Ϫ animals initially created by homologous recombination in embryonic stem cells.
11 C57BL/6 mice (The Jackson Laboratory, Bar Harbor, Me) were used as controls. Animal diet and experiment schedules are shown in Figure 1 . Both the ApoE Ϫ/Ϫ and control mice were weaned at 4 weeks of age and maintained on a chow diet (PicoLab Rodent Chow 20, 4.5% fat by weight, 0.02% cholesterol). After 1 week (ie, at 5 weeks of age), 6 ApoE Ϫ/Ϫ and 6 control (C57BL/6) mice were killed. After 2 weeks (at 6 weeks of age), 12 ApoE Ϫ/Ϫ and 12 control mice were changed to a Western-type diet (Teklad Adjusted Calories Western-type diet, 21% fat by weight, 0.15% cholesterol, 19.5% casein without sodium cholate). The remaining 36 animals (24 ApoE Ϫ/Ϫ and 12 control mice) were maintained on chow. Diet and water were provided ad libitum. The animals were perfusion fixed with 4% paraformaldehyde for 30 minutes. The heart and aorta were then removed and immersion fixed in 4% paraformaldehyde overnight. The aortic sinus, ascending aorta, aortic arch, and abdominal aorta were dissected along a lateral margin. When the aorta was dissected, the surrounding tissue was carefully removed. After the lumen was opened, the aorta was flattened onto a silane-coated slide with superglue (Loctite Corp) to attach each specimen endothelium side up. To allow examination of the aortic sinus on a flat specimen, we dissected away the cusps of the three valves to expose the base of each valve.
In Situ Immunocytochemistry
Staining for each of the adhesion molecules was performed in at least 2 animals from each group and at each time point; specimens were examined by light and electron microscopy. Because the tissues were prepared differently for light microscopy and scanning electron microscopy, each time point was represented by 4 to 6 animals in most cases. Immunocytochemistry was performed as follows. The specimens were blocked with 0.1% goat or rabbit serum in PBS with 1% BSA for 1 hour at RT. They were incubated with the primary antibody at the concentrations listed in the Table for 1 hour at RT. A solution of PBS-1% BSA containing biotinylated rabbit anti-rat IgG (HϩL; dilution, 1:200) and mouse serum (1:100) was applied as a secondary antibody for 1 hour at RT for VCAM-1 staining. The VCAM-1 specimens were incubated with PBS-1% BSA containing 10-nm gold-labeled avidin (1:25) for 1 hour at RT. PBS-1% BSA containing 10-nm gold-conjugated goat anti-rat IgG (1:25) and mouse serum (1:100) was applied for 1 hour at RT for ICAM-1 or PECAM-1 staining. Each step was followed by a wash with PBS performed 3 times. After reaction with the gold-labeled reagents, the specimens were fixed with half-strength Karnovsky's solution overnight at 4°C. Next they were washed with distilled water 3 times and processed with silver enhancement (IntenSETM M) for 7 to 12 minutes at RT. Some specimens were mounted with PBS and examined by light microscopy. The same specimens were observed by scanning electron microscopy (described below). Other specimens were counterstained with Harris hematoxylin or methyl green and mounted with Histomount.
Selected Abbreviations and Acronyms
Immunoelectron Microscopy
For scanning electron microscopy, the specimens were processed with silver enhancement, critical-point dried, sputter-coated with gold-platinum alloy, and observed with the scanning electron microscope (JSM 35C and JSM 6300F, JEOL). For transmission electron microscopy, the specimens were not processed with silver enhancement but were postfixed with osmium, dehydrated with alcohol, and embedded in Medcast (Ted Pella Inc). Thin sections were stained with lead citrate and uranyl acetate and observed by transmission electron microscopy (JEM 1200E XII, JEOL).
Results
The Aortic Arch and Branching Sites of Major Arteries Are Lesion Prone in ApoE؊/؊ Mice
At 5 weeks of age, the aorta of the ApoE Ϫ/Ϫ mouse contained a few, small, isolated lesions, which were detectable by examination with a dissection microscope. By 8 weeks of age, slightly elevated lesions, fatty streaks (by histological examination), 13 develop at lesion-prone sites such as the lesser curvature of the aortic arch and the outflow tract of the brachiocephalic artery ( Figure 2 ). Under the dissection microscope and illumination with reflected light, these sites show grossly elevated, opaque, small, white lesions. At 20 weeks of age, many of these lesions have fused to form larger, more advanced lesions. ApoE Ϫ/Ϫ mice fed the Westerntype diet (plasma cholesterol levels of 1085 to 4402 mg/dL) have larger lesions than those fed the chow diet (plasma cholesterol levels of 360 to 885 mg/dL) for the same period of time. 13 No lesions of atherosclerosis were observed in the control mice fed either diet (plasma cholesterol levels of 101 to 119 mg/dL on chow and 154 to 301 mg/dL on Westerntype diet) for these periods of time.
VCAM-1 Increases at Lesion-Prone Sites in ApoE ؊/؊ Mice
Because VCAM-1, like P-and E-selectin, is involved in the initial tethering and rolling step [5] [6] [7] [8] as well as arrest and firm adhesion 7, 16 in the process of leukocyte infiltration of inflammatory sites, we examined VCAM-1 expression in control mice of 5, 8, and 20 weeks of age. In control mice, only a few ECs weakly stained with antibodies to VCAM-1 in the aortic sinus and in outflow tracts of some small branches of the aorta ( Figure 3A ). The remainder of the aortas from control mice had only a few isolated, weakly stained, VCAM-1-positive cells ( Figure 3B ). No staining was observed with either control antibody (data not shown).
In contrast to control animals, ApoE Ϫ/Ϫ mice showed markedly increased VCAM-1 staining on the surface of the ECs in lesion-prone sites, including the aortic sinus and outflow tracts. At 5 weeks of age, ApoE Ϫ/Ϫ mice had a small number of positive cells with relatively weak staining. By 8 weeks of age, the staining appeared to be more intense, and more positively stained cells were visible in mice fed the Western-type diet (plasma cholesterol at 8 weeks, 2148Ϯ495 mg/dL) than in those fed chow. Some of the VCAM-1-positive cells were located over the lesions or at the periphery of the lesion where no morphological abnormality was observed in the underlying subendothelial space ( Figure 3C ). At 20 weeks on the Westerntype diet (plasma cholesterol, 1959Ϯ315 mg/dL), the number of VCAM-1-positive cells increased, and the cells were located principally in the shoulder region of advanced lesions ( Figure  3D and 3E). Although staining was observed over the "dome" of the lesion, it was weaker than at the shoulder ( Figure 3F ). As observed at 8 weeks, the number of positive cells appeared to be greater in the mice fed the Western-type diet than in those fed chow (data not shown). Thus, VCAM-1 expression has been demonstrated at lesion-prone sites, and the relative level and extent of expression appear to increase with hypercholesterolemia.
Electron microscopy revealed a uniform distribution of VCAM-1 on the smooth surface of each involved EC, with no accentuation at the cell border ( Figure 3G and 3H) . In some cases, VCAM-1 was concentrated at the trailing edge in relation to flow ( Figure 3G ).
Upregulation of ICAM-1 at Lesion-Prone Sites Is Independent of ApoE Deficiency or Diet
ICAM-1 is thought to be involved in the firm adhesion step in leukocyte infiltration. Antibodies to ICAM-1 diffusely stained individual ECs over the aortic surface in both ApoE Ϫ/Ϫ and control mice at 5 and 8 weeks of age. The staining pattern was more intense in lesion-prone sites, such as the lesser curvature of the aortic arch and the orifice of the brachiocephalic artery ( Figure 4 ). However, there was little to no difference either in the pattern of localization or in the intensity of staining of ICAM-1 between ApoE Ϫ/Ϫ mice ( Figure 4A and 4C) and control mice ( Figure 4B ) or between the mice fed the Western-type diet ( Figure 4C ) versus the chow diet ( Figure 4A ). In Figure 4C , the lesser curvature and the orifice of the brachiocephalic artery appear darker because the thickness of the lesions makes them appear dark under transmitted light. Other lesion-prone sites, including the aortic sinus and branching sites in the abdominal aorta, also stained with relatively equivalent intensity, with no apparent differences between ApoE Ϫ/Ϫ and control mice at these sites or between the time points examined (data not shown). By light microscopy, staining for ICAM-1 was primarily localized over the surface of each EC at lesion-prone sites ( Figure 5A ) in both ApoE Ϫ/Ϫ and control mice. At non-lesion-prone sites, staining was mainly confined to the cell periphery ( Figure 5B ). Exceptions to this distribution were lesions in ApoE Ϫ/Ϫ mice at 20 weeks of age, in which ICAM-1 was primarily localized at the borders of the ECs that covered the dome of the advanced lesions ( Figure 5C ), Figure 3E are weakly stained for VCAM-1 (magnification ϫ200). G, VCAM-1, localized with immunogold-labeled particles, is detected over the surface of the ECs by scanning electron microscopy of the surface of the abdominal aorta of an ApoE Ϫ/Ϫ mouse 8 at weeks of age (magnification ϫ2200). Blood flow is from right to left. H, EC denoted by box in Figure 3G is shown at higher magnification, and the cell margins are denoted by open arrows (magnification ϫ10 000).
whereas in the shoulder regions of the lesions, the entire surface of the ECs remained positive for ICAM-1 ( Figure  5D ). The ECs are more polygonal at lesion-prone sites ( Figure 5A ), whereas they are spindle shaped in non-lesionprone sites ( Figure 5B), which suggests that blood flow influences both cell shape and ICAM-1 expression.
Scanning electron microscopy of lesion-prone sites substantiated the presence of ICAM-1 over the smooth surface of the plasma membrane and at the cell periphery ( Figure 5E ), where numerous microvilli appeared "decorated" with immune products ( Figure 5F and 5G, arrows). Microvilli were present on the surface of the bulge occupied by the underlying nucleus and at the cell periphery, and ICAM-1 staining of the microvilli was observed at both lesion-prone and nonlesion-prone sites. In non-lesion-prone areas, ICAM-1 was primarily localized at the cell periphery ( Figure 5H) , and microvilli were not as prominent ( Figure 5I ) as they were at lesion-prone sites ( Figure 5F ). Many adherent leukocytes were observed by scanning electron microscopy in lesionprone sites throughout the aortas of the ApoE Ϫ/Ϫ mice. These leukocytes appeared either as rounded cells, which had no obvious relationship to the endothelial microvilli, or as stretched, flattened cells, which were closely associated with microvilli on the endothelial surface ( Figure 6 ).
PECAM-1 Is Diffusely Localized Throughout the Aorta
PECAM-1 antibodies blocked transendothelial migration of leukocytes in vitro and in vivo. 9, 10 In both ApoE Ϫ/Ϫ and control mice at 5, 8, and 20 weeks of age, antibodies to PECAM-1 stained ECs throughout the aorta. As with ICAM-1 staining, there was no apparent difference in staining intensity between the ApoE Ϫ/Ϫ mice and the controls. However, in contrast to ICAM-1, there were no observable differences between lesionprone sites and other areas, nor was any difference observed on ECs that covered the lesions (data not shown). Light microscopy showed that PECAM-1 was confined principally to the periphery of each cell ( Figure 7 ).
Discussion
Hypercholesterolemia-Associated Upregulation of VCAM-1 Suggests a Role in Lesion Formation and Expansion
Of the three adhesion molecules examined in this study, only VCAM-1 was upregulated at lesion-prone sites by hypercholesterolemia. In mice at 5 and 8 weeks of age, VCAM-1 was expressed on ECs that had no foam cells beneath them. Similar observations were made from transverse sections of the aortas of rabbits fed a high-cholesterol diet for 1 week. 17, 18 These results suggest that VCAM-1 expression is an early event that precedes fatty streak formation and may be important in monocyte recruitment from the blood. In support of this hypothesis, Marui et al 19 found that oxidized LDL, thought to be present in the arterial wall with hypercholesterolemia, including in the ApoE Ϫ/Ϫ mouse, 20 induced VCAM-1 but not ICAM-1 expression in cultured ECs.
In ApoE Ϫ/Ϫ mice at 20 weeks of age, VCAM-1 was localized in the shoulder regions of advanced lesions rather than over the apex of the lesions. This observation is correlated with foam cell accumulation in the shoulder regions of transitional lesions of human atherosclerosis, as Blood flow is from bottom to top. B, In the lateral wall of the aortic arch (lesion-free area) of the same animal in Figure 5A , ICAM-1 immunostaining is localized to the cell periphery (magnification ϫ400). Blood flow is from bottom to top. C, ICAM-1 staining is confined to the cell border of ECs over the advanced lesion in the lesser curvature of an ApoE Ϫ/Ϫ mouse, 20 weeks of age, fed the Western-type diet (magnification ϫ400). Blood flow is from bottom to top. D, The surface of each EC in the shoulder region of the same lesion shown in Figure 5C is diffusely stained for ICAM-1 (magnification ϫ400). Blood flow is from bottom to top. E, Scanning electron photomicrograph of the lesser curvature of the aortic arch (lesion-prone site) of the same animal as in Figure 5A , showing several ECs with diffuse immunostaining over their surfaces (magnification ϫ7000). Blood flow is from bottom to top. F, High-power scanning electron microscopic view of the boxed area in Figure 5E , in which ICAM-1 is localized on the entire cell surface and on the microvilli at the cell periphery (magnification ϫ23 000). G, Transmission electron photomicrograph showing ICAM-1 staining of microvilli protruding from the surface of an EC in the aortic sinus of an ApoE Ϫ/Ϫ mouse (original magnification ϫ30 000). H, Scanning electron photomicrograph of the lateral wall of the aortic arch (lesion-free area) of the same animal as in Figure 5E , showing several ECs with immunostaining localized to the cell periphery (magnification ϫ7000). Blood flow is from bottom to top. I, High-power scanning electron microscopic view of the boxed area in Figure 5H , in which immunoreaction products are located primarily at the cell periphery (arrow) and on the smooth surface (open arrows) in small amounts (magnification ϫ23 000).
pointed out by Daugherty et al. 21 Li et al 17 also noted that VCAM-1 expression appeared particularly elevated at lesion edges and extended several cells beyond the edge. These same regions showed leukocyte recruitment through an intact endothelial monolayer by scanning electron microscopy. These findings suggest that the shoulder is a locus of monocyte recruitment and the site where lesion expansion occurs. Thus, VCAM-1 appears to play a role in both lesion formation and expansion.
Upregulation of VCAM-1 appears to be limited to the endothelial surface of the aortic sinus and a small area of outflow at branch sites in ApoE Ϫ/Ϫ and control mice. Davies et al 22 observed a higher EC turnover rate in cultured endothelium under turbulent flow compared with those under laminar or no flow. Tanaka et al, 23 using balloon injury, suggested that regenerating ECs at the leading edges express VCAM-1. Upregulation of VCAM-1 has also been observed in the rabbit carotid artery in which laminar shear stress was both increased and decreased by surgical manipulation, most significantly with decreased shear. 24 Thus, VCAM-1 may be expressed in normal vessels on regenerating ECs and in outflow tracts at branches where decreased laminar shear stress or increased turbulent flow is present.
VCAM-1 Expression at Lesion-Prone Sites May Significantly Impact Monocyte and Lymphocyte Recruitment
Expression of VCAM-1 appears to increase at lesion-prone sites in hypercholesterolemic animals. For monocytes and lymphocytes, cells that accumulate in lesions of atherosclerosis, VCAM-1 is unique among the three adhesion molecules examined because it allows tethering and rolling of monocytes and lymphocytes, as well as firm adhesion and arrest under physiological conditions, including flow. [5] [6] [7] 25 In vitro data suggest that VCAM-1 may regulate transendothelial migration of monocytes, especially on activated endothelium. 26 -28 Although questions remain regarding the contribution of VCAM-1 to tethering and rolling, 29 involvement of VCAM-1 in the first step of transient interactions may be particularly important for immunoblasts or selectin negative memory T lymphocytes, which lack the ligand for E-selectins that normally regulate the tethering of these leukocytes to arterial endothelium. Although we did not examine P-or E-selectin formation in these studies, both of these molecules may be important in tethering the cells at sites where ICAM and VCAM are upregulated. 18 VCAM-1 is also unique in its interaction with very late-acting antigen-4, where firm adhesion is induced without chemoattractant stimulus. [5] [6] [7] The possibility that VCAM-1 can spontaneously arrest leukocytes and bypass the requirement for chemoattractants is provocative, especially given the expression of VCAM-1 prior to fatty streak formation and in areas apparently devoid of underlying leukocytes (Reverences 17 and 18 and vide infra).
ICAM-1 Levels Are Related to Flow
In the present study, there were no apparent differences in the relative intensity or localization of antibody staining for ICAM-1 in either the ApoE Ϫ/Ϫ or the control mice. The most intensely stained areas were the lesion-prone sites, such as the lesser curvature of the arch and the outflow tracts at branches of major arteries. In the lesion-prone sites the strongly positive ECs appeared more cuboidal than did those in the lightly stained non-lesion-prone areas. The shape of the ECs is related to the level of laminar shear stress. High shear induces elongation of the ECs in the direction of flow. 30 Thus, increased expression of ICAM-1 on the more cuboidal cells suggests that decreased shear, or possibly altered or turbulent flow, may upregulate ICAM-1 expression on the endothelial surface. ICAM-1 also showed lower levels of expression on ECs over the domes of the advanced lesions compared with the ECs that covered the shoulder region, known as the site of expansion of advanced lesions. Because these changes are in lesion-prone sites where ICAM-1 is upregulated at earlier time points, it suggests that local changes in flow or other regulators can decrease expression within these areas.
ICAM-1 and most of the other adhesion molecules can be regulated by cytokines, but only ICAM-1 is regulated by flow in vitro. 31 Resnick et al 32 identified a cis-acting shear stressresponse element within the promoter of the platelet-derived growth factor-B gene, a potent growth factor and chemoat- tractant for smooth muscle cells whose expression is increased in lesions of atherosclerosis. 33 The shear stressresponse element is required for transcriptional upregulation of platelet-derived growth factor-B in ECs exposed to physiological levels of laminar shear stress, and the same shear stress-response element is found within the ICAM-1 promoter region. Nagel et al 31 observed that on exposure to laminar shear stress, ICAM-1 is upregulated in cultured ECs in a time-dependent and force-independent manner compared with static conditions. In contrast, VCAM-1 and PECAM-1, which have no shear stress-response element, are not upregulated by mechanical forces in vitro. En face examination of the normal rabbit carotid artery showed extensive upregulation of ICAM-1 with increased laminar shear, whereas reduced shear suppressed its expression. 24 Although both the in vitro and in vivo manipulation of flow suggests that increased laminar shear is associated with upregulation of ICAM-1, lesion-prone sites of ICAM-1 expression are areas of decreased laminar shear and increased turbulent flow. Focal expression of ICAM-1 has also been noted in normal human vessels, 34 particularly at sites of disturbed flow. 35 Thus, the in vivo and in vitro data suggest that biomechanical forces may play a role in regulating ICAM-1 expression on the ECs.
ICAM-1 Localization on the Smooth Surface of the Plasma Membrane and Microvilli May Also Be Regulated by Flow
By electron microscopy, ICAM-1 is present on both the smooth surface of the plasma membrane and on microvilli in lesion-prone sites, areas of apparent decreased shear or turbulent flow. In contrast, at non-lesion prone sites, ICAM-1 was principally confined to the cell periphery, and microvilli were not as prominent as at lesion-prone sites. VCAM-1 and PECAM-1 were also present on some microvilli, but the numbers of these molecules appear to be qualitatively less frequent than those of ICAM-1 (data not shown). Carpén et al 36 reported that ICAM-1 was expressed on microvilli of transfected COS cells and was associated with the actincontaining cytoskeleton and ␣-actinin. Microvillous receptor presentation is critical for contact initiation under flow conditions. 37 We observed that microvilli are more frequently associated with adherent, spread leukocytes rather than with leukocytes having a rounded profile. Others have observed that blockade of ICAM-1 or ␤2-integrin, the ligand for ICAM-1, inhibited spreading of monocytes on interleukin-4 -stimulated ECs in which VCAM-1 expression is upregulated. 25 ,38 ␤2-Integrin is not expressed on microvilli; rather, it is concentrated on the nonvillous planar cell body of leukocytes. 39 Exclusion of ␤2-integrin from microvilli may ensure its participation in events that follow initial contact.
En face examination of ICAM-1 distribution in the normal rabbit carotid artery also demonstrated junctional localization, 24 similar to our observations in non-lesion-prone sites. Interestingly, reduced shear stress for 5 days in the rabbit carotid artery resulted in a more diffuse distribution of ICAM-1, although lower levels of expression were also observed. Together with our studies, these data suggest that ICAM-1 may be preferentially located on microvilli, and its localization at the cell periphery or over the entire surface of the cell may be regulated by flow.
Expression of PECAM-1 Is Not Related to Lipids or Flow
PECAM-1 has been reported to be constitutively expressed on the endothelium of all vessels, including the aorta, arteries, capillaries, and veins. 34 In the present study, PECAM-1 was equally distributed over the entire surface of the aorta, including advanced lesions. There are no apparent differences in staining intensity between lesion-prone and other sites, ApoE Ϫ/Ϫ and control mice, or younger and older mice, which suggest that PECAM-1 is not regulated by rheological forces, lipid levels, or age. Davies et al 34 observed that all of the ECs expressed PECAM-1 equally throughout the artery, including endothelium over plaques, in human coronary arteries.
PECAM-1 is primarily localized at intercellular junctions. 40 Although the en face methods in the present study do not permit detection of PECAM-1 at these sites, microscopic examination did reveal the localization of PECAM-1 on the surface adjacent to the cell periphery. The distribution at the cell periphery and intercellular junctions may help to explain how this molecule plays a role in transmigration of monocytes between the endothelial junctions. 9 Because a small amount (15%) of PECAM-1 is exposed at the apical surface and the bulk is located in the intercellular junction, Muller et al 9 hypothesized that an apical-basal gradient acts as a haptotactic gradient produces directed migration of monocytes through the junction. Our photomicrographs also suggest that such a gradient of PECAM-1 exists from the center to the periphery of the cell. Such a pattern could help to attract monocytes to the borders of the cells. Thus, PECAM-1 could participate with ICAM-1 and VCAM-1 in the process of lesion initiation. 9, 18 Can the Localization and Repertoire of Adhesion Molecule Expression in the ApoE ؊/؊ Mouse Explain Leukocyte Infiltration in Atherosclerotic Lesions?
Studies of human atherosclerosis suggest that lesion formation represents an inflammatory-fibroproliferative response to altered lipoprotein metabolism, particularly in vascular regions exposed to hemodynamic strain. [41] [42] [43] [44] Monocyte and T-cell infiltration and activation are typical components of human atherosclerotic lesions, which are also observed in lesions of ApoE Ϫ/Ϫ mice. 13, 45, 46 The presence of abundant CD4ϩ T lymphocytes in ApoE Ϫ/Ϫ mice and their expression of CD25, which is indicative of recent activation, suggest that immune activation is part of lesion formation. 46 These authors also found abundant class II major histocompatibility complex expression on macrophages, which suggests release of cytokines from activated T cells. Thus, the immunophenotype of the murine ApoE Ϫ/ lesions closely resembles that of human lesions.
We have qualitatively characterized a distinct pattern of adhesion molecule expression in the ApoE Ϫ/Ϫ mice at lesion-prone sites. PECAM-1 is diffusely localized throughout the aorta, but it is particularly concentrated at the cell periphery. Of the molecules we studied, only VCAM-1 appeared to be induced in response to hypercholesterolemia and its associated changes, including increased levels of oxidized lipoproteins. In contrast, the relative expression of ICAM-1 was not altered by the presence or absence of hypercholesterolemia at lesion-prone sites. ICAM-1 was primarily localized over the surface of ECs and was prominent on microvilli. Although our analysis was limited to these three adhesion molecules, their specificity and pattern of expression may account for a significant proportion of the lymphocyte and monocyte recruitment observed in ApoE Ϫ/Ϫ lesions. VCAM-1 expression precedes leukocyte accumulation, can initiate both monocyte and lymphocyte tethering and rolling, and can induce firm adhesion in the absence of chemoattractants. At lesion-prone sites, ICAM-1 localization on microvilli will enhance firm adhesion for leukocytes in the primary, transient adhesion step, and increased expression of ICAM-1 over the surface of the endothelium will promote cell arrest where cell-cell contact has already been established. Finally, transendothelial cell migration, which leads to subendothelial deposition of the leukocytes and formation of early fatty streaks, is supported by universally expressed PECAM-1 as well as possibly enhanced by locally expressed VCAM-1.
Our studies suggest that VCAM-1 and ICAM-1 may coordinately define the lesion-prone sites. In particular, what impact would blockade of VCAM-1 have on the formation of lesions of atherosclerosis? Analysis of VCAM-1-deficient mice has been difficult because few of the homozygousdeficient mice are viable. 47 Phenotypic analysis suggests that VCAM-1 is required for development of the extraembryonic circulatory system and embryonic heart. 47, 48 However, in future studies it will be important to analyze the impact of VCAM-1 inhibition, as our data strongly support a role for VCAM-1 in both the initiation and progression of lesions of atherosclerosis.
